Gene therapies are proving their worth, but with million dollar price tags, it’s not clear who should pay for them – The Conversation UK
The Conversation UK |
Gene therapies are proving their worth, but with million dollar price tags, it's not clear who should pay for them
The Conversation UK That's because gene therapies became a clinical reality in 2017. Yet many people with rare diseases that could be treated in this way may never benefit from these therapies because they are too expensive for drug companies to develop, or too costly for … |
